COVID-19 update: Sept. 8, 2022
FDA authorizes booster; Updated guidance from CDC for immunocompromised and NIH on monoclonal antibodies; and COVID-19 Summary of Evidence updated
Monitoring report available for lower respiratory testing of lung donors
Policy that requires SARS-CoV-2 lower respiratory testing of lung donors went into effect May 27.
Lower respiratory testing of all potential lung donors for SARS-CoV-2 now required
Policy is intended to address patient safety.
Lower respiratory testing requirement for all lung donors to be considered
At its April 26 virtual meeting, the OPTN Executive Committee will consider an emergency policy to require lower respiratory COVID-19 testing for all potential lung donors.
Effective April:1 Data amnesty status for follow-up forms ends
Transplant hospitals are responsible for completing these forms by July 1, 2021.
Resource lists lower respiratory tract testing available
Tests authorized by the FDA to analyze lower respiratory tract specimens.